Professor of Radiology, Massachusetts General Hospital

Radiology

Daniel B. Kopans practices Radiology. He graduated from Harvard Medical School. Harvard Medical School is one of the top medical schools in the US. Harvard Medical School has a rank of 1 in research and a 12 in primary care He received awards:"Super Doctor". Dr. Daniel B. Kopans is a published doctor as well. He has 100 publications published. The latest was: "Off Label" Use of FDA-Approved Devices and Digital Breast Tomosynthesis.

Publications

---

• "Off Label" Use of FDA-Approved Devices and Digital Breast Tomosynthesis.
• Reply to "tomosynthesis assisting in localization of breast lesions for ultrasound targeting seen on one mammographic view only".
• The 20-year effort to reduce access to mammography screening: Historical facts dispute a commentary in Cancer.
• A new era in mammography screening.
• Digital breast tomosynthesis from concept to clinical care.
• Reply to A failure analysis of invasive breast cancer: Most deaths from disease occur in women not regularly screened.
• Development of wire localization for occult breast lesions: Boston remembrances.
• A failure analysis of invasive breast cancer: Most deaths from disease occur in women not regularly screened.
• Digital breast tomosynthesis: a better mammogram.
• Do not jump too quickly to conclusions.
• Just the facts: mammography saves lives with little if any radiation risk to the mature breast.
• Mammographic screening and "overdiagnosis".
• Combined optical and X-ray tomosynthesis breast imaging.
• The U.S. Preventive Services Task Force guidelines are not supported by the scientific evidence.
• The 2009 US Preventive Services Task Force (USPSTF) guidelines are not supported by science: the scientific support for mammography screening.
• Characterization of masses in digital breast tomosynthesis: comparison of machine learning in projection views and reconstructed slices.
• Re: "Quality of life and diagnostic imaging outcomes".
• Re: "Saving lives: mammograms, breast cancer, and health insurance reform".
• The 2009 U.S. Preventive Services Task Force guidelines ignore important scientific evidence and should be revised or withdrawn.
• The recent US preventive services task force guidelines are not supported by the scientific evidence and should be rescinded.
• Cost-effectiveness of breast MR imaging and screen-film mammography for screening BRCA1 gene mutation carriers.
• Compositional-prior-guided image reconstruction algorithm for multi-modality imaging.
• Mammography: yet another challenge.
• Enhanced imaging of microcalcifications in digital breast tomosynthesis through improved image-reconstruction algorithms.
• Combined optical imaging and mammography of the healthy breast: optical contrast derived from breast structure and compression.
• The American Cancer Society guidelines for breast screening with magnetic resonance imaging: an argument for genetic testing.
• Regional admittivity spectra with tomosynthesis images for breast cancer detection: preliminary patient study.
• Cutaneous caves and subcutaneous adipose columns in the breast: radiologic-pathologic correlation.
• The science is needed.
• LCIS found at core needle biopsy may not need surgical excision.
• Computer-aided detection of masses in digital tomosynthesis mammography: comparison of three approaches.
• DMIST results: technologic or observer variability?
• Detecting nonpalpable recurrent breast cancer: the role of routine mammographic screening of transverse rectus abdominis myocutaneous flap reconstructions.
• Breast cancer screening in BRCA1 mutation carriers: effectiveness of MR imaging--Markov Monte Carlo decision analysis.
• History repeats.
• Basic physics and doubts about relationship between mammographically determined tissue density and breast cancer risk.
• Screening mammography for women age 40 to 49 years.
• Blinded comparison of computer-aided detection with human second reading in screening mammography.
• Accuracy of self-reported personal history of cancer in an outpatient breast center.
• Mammographic breast density.
• Mammographic breast density and race.
• Regional admittivity spectra with tomosynthesis images for breast cancer detection.
• Long-term risk of false-positive screening results and subsequent biopsy as a function of mammography use.
• Voting strategy for artifact reduction in digital breast tomosynthesis.
• The effect of changes in tumor size on breast carcinoma survival in the U.S.: 1975-1999.
• Radiological reasoning: male breast mass with calcifications.
• Computer-aided detection system for breast masses on digital tomosynthesis mammograms: preliminary experience.
• Case records of the Massachusetts General Hospital. Case 35-2005. A 56-year-old woman with breast cancer and isolated tumor cells in a sentinel lymph node.
• Prevalence of hereditary breast/ovarian carcinoma risk in patients with a personal history of breast or ovarian carcinoma in a mammography population.
• Case records of the Massachusetts General Hospital. Case 24-2005. A 58-year-old woman with early-stage estrogen-receptor-positive breast cancer.
• Informed decision making: age of 50 is arbitrary and has no demonstrated influence on breast cancer screening in women.
• Physiologic changes in breast magnetic resonance imaging during the menstrual cycle: perfusion imaging, signal enhancement, and influence of the T1 relaxation time of ...
• Bias in the medical journals: a commentary.
• Chopped liver again!
• Hormone replacement therapy in postmenopausal women: breast tissue perfusion determined with MR imaging--initial observations.
• Evaluation of hereditary risk in a mammography population.
• Prospective comparison of mammography, sonography, and MRI in patients undergoing neoadjuvant chemotherapy for palpable breast cancer.
• Coregistered tomographic x-ray and optical breast imaging: initial results.
• Lobular neoplasia on core-needle biopsy--clinical significance.
• Be careful to not willingly suspend disbelief.
• Get the facts straight.
• The age at which women begin mammographic screening.
• The mammary hamartoma: appreciation of additional imaging characteristics.
• A comparison of reconstruction algorithms for breast tomosynthesis.
• Re: Decreasing women's anxieties after abnormal mammograms: a controlled trial.
• Mammographic screening: patterns of use and estimated impact on breast carcinoma survival.
• Sonography should not be used for breast cancer screening until its efficacy has been proven scientifically.
• Mammography screening is saving thousands of lives, but will it survive medical malpractice?
• Effect of tamoxifen on breast tissue density in premenopausal breast cancer.
• Screening for cancer: when is it valid?--Lessons from the mammography experience.
• What is wrong with this picture? Screening mammography.
• Breast sonographic screening is not ready for prime time.
• Breast cancer detection by mapping hemoglobin concentration and oxygen saturation.
• Breast imaging and the symptomatic patient: enough with the "diagnostic" mammography.
• Tomographic optical breast imaging guided by three-dimensional mammography.
• Mammographic screening for breast cancer.
• Older is better.
• Invasive ductal breast carcinoma response to neoadjuvant chemotherapy: noninvasive monitoring with functional MR imaging pilot study.
• A simple model of breast carcinoma growth may provide explanations for observations of apparently complex phenomena.
• Re: Association of volume and volume-independent factors with accuracy in screening mammogram interpretation.
• Effectiveness of US breast cancer screening remains to be demonstrated.
• The lactating breast: MRI findings and literature review.
• Gene-expression signatures in breast cancer.
• Re: Detection of ductal carcinoma in situ in women undergoing screening mammography.
• Another view of mammography and beyond.
• Tomographic mammography using a limited number of low-dose cone-beam projection images.
• The most recent breast cancer screening controversy about whether mammographic screening benefits women at any age: nonsense and nonscience.
• Invasive lobular carcinoma: spectrum of enhancement and morphology on magnetic resonance imaging.
• Specificity of mammography and US in the evaluation of a palpable abnormality: retrospective review.
• Predicting the survival of patients with breast carcinoma using tumor size.
• Re: All-cause mortality in randomized trials of cancer screening.
• Occult contralateral breast carcinoma incidentally detected by breast magnetic resonance imaging.
• Chopped liver...all over again.
• Breast cancer: regional blood flow and blood volume measured with magnetic susceptibility-based MR imaging--initial results.
• Negative mammographic and US findings do not help exclude breast cancer.
• Ten criteria for effective screening.
• Beyond randomized controlled trials: organized mammographic screening substantially reduces breast carcinoma mortality.
• The pattern of breast cancer screening utilization and its consequences.
• Arguments Against Mammography Screening Continue to be Based on Faulty Science.

Schools

---

• Harvard Medical School

• Mary Hitchcock Hospital Darmout

• Massachusetts General Hospital

Doctors Specialties

---

• Diagnostic Radiology
• Radiology

Accepted Insurances

---

Awards

---

• Super Doctor

Education

---

• Massachusetts General Hospital
• Dartmouth-Hitchcock Medical Center
• Harvard Medical School

Helpful Reviews

---

Give Anonymous Review

Similar Doctors

---

	Dr. James H. Thrall, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Ashraf Thabet, MD This Doctor is OpenDoctor Recommended.
	Dr. Jacob L. Jaremko, MD This Doctor is OpenDoctor Recommended.
	Dr. Reza Habibi, MD This Doctor is OpenDoctor Recommended.
	Gillian B. Lieberman, MB BCH
	Anandkumar H. Singh, MB BS
	Dr. McKinley Glover IV, MD This Doctor is OpenDoctor Recommended.
	Dr. Michael J. Deleo, MD
	Dr. Hannah Perry, MD This Doctor is OpenDoctor Recommended.
	Dr. Harlan B. Harvey, MD This Doctor is OpenDoctor Recommended.
	Dr. Katherine D. Rose, MD This Doctor is OpenDoctor Recommended.
	Dr. Eva Gombos, MD This Doctor is OpenDoctor Recommended.
	Dr. Florian J. Fintelmann, MD This Doctor is OpenDoctor Recommended.
	Dr. Jeffrey G. Brooks, MD This Doctor is OpenDoctor Recommended.
	Dr. Ewa Kuligowska, MD This Doctor is OpenDoctor Recommended.

---

Doctor Directory | TOS | twitter | FB | Angel | blog